Efficacy and Safety of Pembrolizumab in Non-Small Cell Lung Cancer in Our Institution: A Retrospective Study

被引：0
|
作者：
Saijo, N. [1 ]
Inagaki, Y. [1 ]
Abe, Y. [1 ]
Kono, S. [1 ]
Taniguchi, Y. [1 ]
Otsuka, K. [1 ]
Naoki, Y. [1 ]
Tamiya, A. [1 ]
Okishio, K. [1 ]
Atagi, S. [2 ]
机构：
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Internal Med, Sakai, Osaka, Japan
[2] Kinki Chuo Chest Med Ctr, Med Oncol, Sakai, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Pembrolizumab institution retrospective;
D O I：
10.1016/j.jtho.2018.08.1647
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-87
引用
收藏
页码：S900 / S900
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer
    Kartolo, A.
    Holstead, R.
    Hopman, W.
    Young, L.
    Baetz, T.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (01) : 87 - 95
  • [22] Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustments
    Gower, Arjan
    Garon, Edward B.
    TRANSLATIONAL CANCER RESEARCH, 2022,
  • [23] Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
    Burgos-San Jose, Amparo
    Colomer-Aguilar, Claudia
    Martinez-Caballero, Daniel
    Massuti-Sureda, Bartomeu
    FARMACIA HOSPITALARIA, 2021, 45 (03) : 121 - 125
  • [24] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
    Kaburagi, Takayuki
    Satoh, Hiroaki
    Hayashihara, Kenji
    Endo, Takeshi
    Hizawa, Nobuyuki
    Kurishima, Koichi
    Nishimura, Yoshihiro
    Hashimoto, Toshio
    Nakamura, Hiroyuki
    Kishi, Koji
    Inagaki, Masaharu
    Nawa, Takeshi
    Ichimura, Hideo
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Fukuoka, Toshihiko
    Shinohara, Yoko
    Kamiyama, Koichi
    Sato, Yukio
    Sakai, Mitsuaki
    Matsumura, Takeshi
    Uchiumi, Keiko
    Furukawa, Kinya
    ONCOLOGY LETTERS, 2013, 5 (02) : 435 - 439
  • [25] Non-small cell lung cancer therapy: safety and efficacy in the elderly
    Glotzer, Owen S.
    Fabian, Thomas
    Chandra, Anurag
    Bakhos, Charles T.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2013, 5 : 113 - 121
  • [26] Safety and Efficacy of Vinorelbine in the Treatment of Non-Small Cell Lung Cancer
    Faller, Bryan A.
    Pandit, Trailokya N.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 131 - 144
  • [27] Efficacy and safety of Navelbine® oral in non-small cell lung cancer
    Zatloukal, P
    Jassem, J
    Depierre, A
    Ramlau, R
    Mlodkowska, HK
    Krawczyk, K
    Krzakowski, M
    Lemarié, E
    O'Brien, M
    His, P
    Lefresne-Soulas, F
    LUNG CANCER: CURRENT TOPICS, 2001, : 353 - 357
  • [28] Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study
    Fujimoto, Daichi
    Yoshioka, Hiroshige
    Kataoka, Yuki
    Morimoto, Takeshi
    Kim, Young Hak
    Tomii, Keisuke
    Ishida, Tadashi
    Hirabayashi, Masataka
    Hara, Satoshi
    Ishitoko, Manabu
    Fukuda, Yasushi
    Hwang, Moon Hee
    Sakai, Naoki
    Fukui, Motonari
    Nakaji, Hitoshi
    Morita, Mitsunori
    Mio, Tadashi
    Yasuda, Takehiro
    Sugita, Takakazu
    Hirai, Toyohiro
    LUNG CANCER, 2018, 119 : 14 - 20
  • [29] Efficacy and safety of TS-ONE in advanced non-small cell lung cancer in Thailand: a multicenter retrospective study
    Maneenil, K.
    Korphaisarn, K.
    Prasongsook, N.
    Vinayanuwattikun, C.
    Sunraweravong, P.
    Chindaprasirt, J.
    Sriuranpong, V.
    Akewanlop, C.
    Baisamut, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1379 - S1380
  • [30] Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: A retrospective clinical study
    Yuan, Dong-mei
    Lv, Yan-ling
    Yao, Yan-wen
    Miao, Xiao-hui
    Wang, Qian
    Xiao, Xin-wu
    Yin, Jie
    Shi, Yi
    Shi, Mei-qi
    Zhang, Xiu-wei
    Song, Yong
    THORACIC CANCER, 2012, 3 (04) : 341 - 347
12345